Free ophthalmic AI model
Researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology have developed an artificial intelligence (AI) system with the potential to identify eye diseases, heart attacks, stroke and
Staff reporters2 min read
Ophthalmology News
NPi to evaluate brain injury outcomes
An international study found the neurological pupil index (NPi) is an effective means to evaluate disease progression and predict outcomes for acute brain injury patients. The ‘Orange’ study
Staff reporters2 min read
Women seen but not heard
Women are three times less likely to be among the first to ask questions at ophthalmology grand rounds (GR) sessions, according to a US study. Researchers led by Dr Lauren Hennein, University of
Staff reporters1 min read
‘Atlas’ of eye-cell genes unveiled
A US research team said it hopes its new ‘eye atlas’, detailing which eye cell types express certain disease-associated genes, will support the design of effective therapeutic strategies to avoid
Staff reporters1 min read
Established and emerging trends in AMD management
One of the most exciting facets of being medical retina specialists is the continued evolution of age-related macular degeneration (AMD) therapies. We have come a long way from the days of
Drs Jo Sims and Ainsley Morris12 min read
Sharpened focus on learning and awareness
After the challenging Covid years, Macular Degeneration New Zealand (MDNZ) is back and re-engaging with health professionals, offering more learning opportunities from October 2023.
Staff reporters3 min read
Real-time pollen monitoring project unveiled
Asthma and allergy researchers have installed a pollen trap on the roof of the Auckland War Memorial Museum Tāmaki Paenga Hira to gather near-real-time data on airborne pollen and spores that can trigger a range of allergic reactions.
Staff reporters3 min read
Policies boost doctor numbers
The government’s proposal to train an additional 95 doctors each year from 2025 to 2027, on top of the 50 additional places announced for 2024, has been met with mixed responses. An additional 285
Staff reporters2 min read
Trial success for IV TED treatment
Viridian Therapeutics announced trial results of its intravenously delivered treatment for chronic thyroid eye disease (TED), showing patients experienced reductions in proptosis and improvements in their clinical activity scores.
Staff reporters1 min read
Progress for DED peptide treatment
A novel synthetic peptide with anti-inflammatory properties potentially suited to DED management is the subject of a phase 2 clinical trial.
Staff reporters1 min read
Māori’s higher treatment-injury risk
Māori are a third more likely to be admitted to hospital with injuries resulting from healthcare and are 43% more likely to be admitted because of healthcare complications compared with non-Māori, reported researchers from the University of Auckland.
Staff reporters2 min read
Identifying inflammation in dry eye disease
Inflammation plays a key role in triggering and propagating dry eye disease (DED) via the ‘vicious circle’1. In severe cases, topical anti-inflammatory therapy may be indicated, but managing a patient’s meibomian gland dysfunction can often be sufficient to resolve ocular surface inflammation withou
Catherine Jennings3 min read